{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T07:43:16Z","timestamp":1695195796102},"posted":{"date-parts":[[2023,1,13]]},"group-title":"In Review","reference-count":27,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Polymorphisms thiopurine-S-methyltransferase (<jats:italic>TPMT<\/jats:italic>) and nudix hydrolase 15 (<jats:italic>NUDT15<\/jats:italic>) can increase the risk of azathioprine myelotoxicity, but little is known about other genetic factors that increase risk for azathioprine-associated side effects. PrediXcan is a gene-based association method that estimates the expression of individuals\u2019 genes and examines their correlation to specified phenotypes. As proof of concept for using PrediXcan as a tool to define the association between genetic factors and azathioprine side effects, we aimed to determine whether the genetically predicted expression of TPMT or NUDT15 was associated with leukopenia or other known side effects. In a retrospective cohort of 1364 new users of azathioprine with EHR-reported White race, we used PrediXcan to impute expression in liver tissue, tested its association with pre-specified phecodes representing known side effects (e.g., skin cancer), and completed chart review to confirm cases. Among confirmed cases, patients in the lowest tertile (i.e., lowest predicted) of TPMT expression had significantly higher odds of developing leukopenia (OR=3.30, 95%CI: 1.07-10.20, p=0.04) versus those in the highest tertile; no other side effects were significant. The results suggest that this methodology could be deployed on a larger scale to uncover associations between genetic factors and drug side effects for more personalized care.<\/jats:p>","DOI":"10.21203\/rs.3.rs-2444787\/v1","type":"posted-content","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T18:17:21Z","timestamp":1673633841000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Genetically Predicted Expression of TPMT and Azathioprine Adverse Events"],"prefix":"10.21203","author":[{"given":"Alyssa","family":"Davis","sequence":"first","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson L.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Daniel","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puran","family":"Nepal","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacy","family":"Zanussi","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyne W.","family":"Miller-Fleming","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Straub","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qi","family":"Wei","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy J.","family":"Cox","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana M.","family":"Hung","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QiPing","family":"Feng","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"Stein","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia P.","family":"Chung","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","article-title":"Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience","volume":"34","author":"Connell WR","year":"1993","unstructured":"Connell, W. R., Kamm, M. A., Ritchie, J. K. & Lennard-Jones, J. E. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 34, 1081\u20131085 (1993).","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard L","year":"1989","unstructured":"Lennard, L., Van Loon, J. A. & Weinshilboum, R. M. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 46, 149\u2013154, doi:10.1038\/clpt.1989.119 (1989).","journal-title":"Clin Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update","volume":"105","author":"Relling MV","year":"2019","unstructured":"Relling, M. V. et al. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. Clin Pharmacol Ther 105, 1095\u20131105, doi:10.1002\/cpt.1304 (2019).","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/cpt.2428","article-title":"TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results","volume":"111","author":"Dickson AL","year":"2022","unstructured":"Dickson, A. L. et al. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. Clin Pharmacol Ther 111, 263\u2013271, doi:10.1002\/cpt.2428 (2022).","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/ard.41.suppl_1.44","article-title":"Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities","volume":"41","author":"Whisnant JK","year":"1982","unstructured":"Whisnant, J. K. & Pelkey, J. Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. Ann Rheum Dis 41 Suppl 1, 44\u201347, doi:10.1136\/ard.41.suppl_1.44 (1982).","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/MIB.0000000000001163","article-title":"More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing","volume":"23","author":"Broekman M","year":"2017","unstructured":"Broekman, M. et al. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing. Inflamm Bowel Dis 23, 1873\u20131881, doi:10.1097\/MIB.0000000000001163 (2017).","journal-title":"Inflamm Bowel Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/(sici)1097-0142(19990915)86:6<1080::aid-cncr26>3.0.co;2-5","article-title":"Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism","volume":"86","author":"Bo J","year":"1999","unstructured":"Bo, J. et al. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer 86, 1080\u20131086, doi:10.1002\/(sici)1097-0142(19990915)86:6<1080::aid-cncr26>3.0.co;2-5 (1999).","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ng.3367","article-title":"A gene-based association method for mapping traits using reference transcriptome data","volume":"47","author":"Gamazon ER","year":"2015","unstructured":"Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat Genet 47, 1091\u20131098, doi:10.1038\/ng.3367 (2015).","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/cts.12522","article-title":"Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records","volume":"11","author":"Robinson JR","year":"2018","unstructured":"Robinson, J. R., Denny, J. C., Roden, D. M. & Van Driest, S. L. Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records. Clin Transl Sci 11, 112\u2013122, doi:10.1111\/cts.12522 (2018).","journal-title":"Clin Transl Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-020-0163-4","article-title":"Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practice","author":"Anandi P","year":"2020","unstructured":"Anandi, P. et al. Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practice. Pharmacogenomics J, doi:10.1038\/s41397-020-0163-4 (2020).","journal-title":"Pharmacogenomics J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13059-020-02113-0","article-title":"Impact of admixture and ancestry on eQTL analysis and GWAS colocalization in GTEx","volume":"21","author":"Gay NR","year":"2020","unstructured":"Gay, N. R. et al. Impact of admixture and ancestry on eQTL analysis and GWAS colocalization in GTEx. Genome Biol 21, 233, doi:10.1186\/s13059-020-02113-0 (2020).","journal-title":"Genome Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1752-8062.2010.00175.x","article-title":"Principles of human subjects protections applied in an opt-out, de-identified biobank","volume":"3","author":"Pulley J","year":"2010","unstructured":"Pulley, J., Clayton, E., Bernard, G. R., Roden, D. M. & Masys, D. R. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci 3, 42\u201348, doi:10.1111\/j.1752-8062.2010.00175.x (2010).","journal-title":"Clin Transl Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden DM","year":"2008","unstructured":"Roden, D. M. et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 84, 362\u2013369, doi:10.1038\/clpt.2008.89 (2008).","journal-title":"Clin Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ajhg.2022.02.013","article-title":"Predicted gene expression in ancestrally diverse populations leads to discovery of susceptibility loci for lifestyle and cardiometabolic traits","volume":"109","author":"Highland HM","year":"2022","unstructured":"Highland, H. M. et al. Predicted gene expression in ancestrally diverse populations leads to discovery of susceptibility loci for lifestyle and cardiometabolic traits. Am J Hum Genet 109, 669\u2013679, doi:10.1016\/j.ajhg.2022.02.013 (2022).","journal-title":"Am J Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/m21-4675","article-title":"Race, Genotype, and Azathioprine Discontinuation: A Cohort Study","author":"Dickson AL","year":"2022","unstructured":"Dickson, A. L. et al. Race, Genotype, and Azathioprine Discontinuation: A Cohort Study. Ann Intern Med, doi:10.7326\/m21-4675 (2022).","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das S","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat Genet 48, 1284\u20131287, doi:10.1038\/ng.3656 (2016).","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","article-title":"Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology","volume":"16","author":"Broen JCA","year":"2020","unstructured":"Broen, J. C. A. & van Laar, J. M. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nature reviews. Rheumatology 16, 167\u2013178, doi:10.1038\/s41584-020-0374-8 (2020).","journal-title":"Nature reviews. Rheumatology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","article-title":"Reference-based phasing using the Haplotype Reference Consortium panel","volume":"48","author":"Loh P-R","year":"2016","unstructured":"Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nature Genetics 48, 1443\u20131448, doi:10.1038\/ng.3679 (2016).","journal-title":"Nature Genetics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype\u2014Tissue Expression (GTEx) project","volume":"45","author":"TEx Consortium","year":"2013","unstructured":"G. TEx Consortium. The Genotype\u2014Tissue Expression (GTEx) project. Nat Genet 45, 580\u2013585, doi:10.1038\/ng.2653 (2013).","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak B","year":"2013","unstructured":"Pasternak, B., Svanstr\u00f6m, H., Schmiegelow, K., Jess, T. & Hviid, A. Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol 177, 1296\u20131305, doi:10.1093\/aje\/kws375 (2013).","journal-title":"Am J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00042737-200402000-00014","article-title":"Side effects of azathioprine in patients with Crohn's disease","volume":"16","author":"Jong DJ","year":"2004","unstructured":"de Jong, D. J., Goullet, M. & Naber, T. H. Side effects of azathioprine in patients with Crohn's disease. European journal of gastroenterology & hepatology 16, 207\u2013212, doi:10.1097\/00042737-200402000-00014 (2004).","journal-title":"European journal of gastroenterology & hepatology"},{"key":"ref22","unstructured":"FDA. Azathioprine package insert, <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/016324s034s035lbl.pdf> (2011)."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/bioinformatics\/btq126","article-title":"PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene\u2013disease associations","volume":"26","author":"Denny JC","year":"2010","unstructured":"Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene\u2013disease associations. Bioinformatics 26, 1205\u20131210, doi:10.1093\/bioinformatics\/btq126 (2010).","journal-title":"Bioinformatics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris, P. A. et al. The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics 95, 103208, doi:https:\/\/doi.org\/10.1016\/j.jbi.2019.103208 (2019).","journal-title":"Journal of Biomedical Informatics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 42, 377\u2013381, doi:https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010 (2009).","journal-title":"Journal of Biomedical Informatics"},{"key":"ref26","unstructured":"Stata Statistical Software: Release 17 (StataCorp LLC, College Station, TX, 2021)."},{"key":"ref27","unstructured":"R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2021)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2444787\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2444787\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T12:59:40Z","timestamp":1695128380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2444787\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":27,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2444787\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,1,13]]},"subtype":"preprint"}}